BCI Pharma
Grabels
About BCI Pharma
BCI Pharma designs and synthesizes kinase inhibitor libraries. They identify novel, potent, and selective kinase inhibitor hits. They develop cell-based assays. They also plan to deliver medications for inflammatory diseases, CNS disorders, and cancer. Their goal is to create a world-renowned firm that its patients, customers, investors, business partners, and the communities where they work and live regard highly.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Last round: Series Unknown (Mar 2018)
- Website: bci-pharma.com
Industries & Categories
Biotechnology, Business Development, Finance, Health Care, Innovation Management
Social Profiles
Canonical: https://fsome.com/organization/bci-pharma-100845 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.